1. Cortical overgrowth in a preclinical forebrain organoid model of CNTNAP2-associated autism spectrum disorder
- Author
-
Yan Sun, Kevin A. Strauss, Raju Tomer, Bin Xu, Christoph Kellendonk, Sander Markx, Bianca Migliori, Job O. de Jong, Steven A. Kushner, Francesco Gavino Brundu, Giuseppe P. Cortese, Ceyda Llapashtica, Matthieu Genestine, Jonathan A. Javitch, Huixiang Zhu, Frank A. Provenzano, Barbara Corneo, Karlla W. Brigatti, and Psychiatry
- Subjects
CNTNAP2 ,Cell type ,Adolescent ,Autism Spectrum Disorder ,Cellular differentiation ,Science ,Induced Pluripotent Stem Cells ,General Physics and Astronomy ,Nerve Tissue Proteins ,Biology ,Article ,General Biochemistry, Genetics and Molecular Biology ,Prosencephalon ,Organoid ,Humans ,Genetic Predisposition to Disease ,Child ,Induced pluripotent stem cell ,Cell Proliferation ,Neurons ,Multidisciplinary ,Sequence Analysis, RNA ,Membrane Proteins ,Cell Differentiation ,General Chemistry ,Autism spectrum disorders ,Phenotype ,Embryonic stem cell ,Organoids ,Mutation ,Forebrain ,Female ,Neuroscience - Abstract
We utilized forebrain organoids generated from induced pluripotent stem cells of patients with a syndromic form of Autism Spectrum Disorder (ASD) with a homozygous protein-truncating mutation in CNTNAP2, to study its effects on embryonic cortical development. Patients with this mutation present with clinical characteristics of brain overgrowth. Patient-derived forebrain organoids displayed an increase in volume and total cell number that is driven by increased neural progenitor proliferation. Single-cell RNA sequencing revealed PFC-excitatory neurons to be the key cell types expressing CNTNAP2. Gene ontology analysis of differentially expressed genes (DEgenes) corroborates aberrant cellular proliferation. Moreover, the DEgenes are enriched for ASD-associated genes. The cell-type-specific signature genes of the CNTNAP2-expressing neurons are associated with clinical phenotypes previously described in patients. The organoid overgrowth phenotypes were largely rescued after correction of the mutation using CRISPR-Cas9. This CNTNAP2-organoid model provides opportunity for further mechanistic inquiry and development of new therapeutic strategies for ASD., Mutations in CNTNAP2 have been associated with a syndromic form of Autism Spectrum Disorder. Here the authors show that forebrain organoids generated from induced pluripotent stem cells of patients with a syndromic form of ASD with a homozygous truncating mutation in CNTNAP2 displayed an increase in volume and total cell number, which is driven by abnormal cellular proliferation and neurogenesis.
- Published
- 2021